D W Warnock
Overview
Explore the profile of D W Warnock including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
157
Citations
2732
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lasker B, Elie C, Lott T, Espinel-Ingroff A, Gallagher L, Kuykendall R, et al.
Med Mycol
. 2001 Sep;
39(4):341-52.
PMID: 11556764
Candida albicans strain diversity and fluconazole resistance were prospectively analyzed in oral strains from 29 adult human immunodeficiency virus (HIV)-positive patients followed for > 1 year who had five or...
12.
McNeil M, NASH S, Hajjeh R, Phelan M, Conn L, Plikaytis B, et al.
Clin Infect Dis
. 2001 Aug;
33(5):641-7.
PMID: 11486286
To determine national trends in mortality due to invasive mycoses, we analyzed National Center for Health Statistics multiple-cause-of-death record tapes for the years 1980 through 1997, with use of their...
13.
Lyon G, Smilack J, Komatsu K, Pasha T, Leighton J, Guarner J, et al.
Clin Infect Dis
. 2001 Apr;
32(10):1448-55.
PMID: 11317246
Gastrointestinal basidiobolomycosis (GIB) is an unusual fungal infection that is rarely reported in the medical literature. From April 1994 through May 1999, 7 cases of GIB occurred in Arizona, 4...
14.
Espinel-Ingroff A, Warnock D, Vazquez J
Med Mycol
. 2001 Feb;
38 Suppl 1:293-304.
PMID: 11204157
As new antifungal agents are introduced for the treatment of infections caused by yeasts and filamentous fungi (moulds), it is important that reliable methods are available for the in vitro...
15.
16.
James M, Lasker B, McNeil M, Shelton M, Warnock D, Reiss E
J Clin Microbiol
. 2000 Oct;
38(10):3612-8.
PMID: 11015372
Aspergillus flavus is second to A. fumigatus as a cause of invasive aspergillosis, but no standard method exists for molecular typing of strains from human sources. A repetitive DNA sequence...
17.
Warnock D, Morrison C
Antimicrob Agents Chemother
. 2000 Jul;
44(8):2081-5.
PMID: 10898679
MIC end point determination for the most commonly prescribed azole antifungal drug, fluconazole, can be complicated by "trailing" growth of the organism during susceptibility testing by the National Committee for...
18.
Williamson E, Oliver D, Johnson E, Foot A, Marks D, Warnock D
J Clin Pathol
. 2000 Jul;
53(5):362-6.
PMID: 10889818
Aims: To assess the clinical usefulness of a commercial aspergillus antigen enzyme linked immunosorbent assay (ELISA) in the diagnosis of invasive aspergillosis (IA) in bone marrow transplant recipients, and to...
19.
Motley M, Warnock D, Morrison C
J Clin Microbiol
. 2000 Jun;
38(6):2254-60.
PMID: 10834985
The PASCO antifungal susceptibility test system, developed in collaboration with a commercial company, is a broth microdilution assay which is faster and easier to use than the reference broth microdilution...
20.
Li R, Ciblak M, Nordoff N, Pasarell L, Warnock D, McGinnis M
Antimicrob Agents Chemother
. 2000 May;
44(6):1734-6.
PMID: 10817743
The in vitro activity of voriconazole was compared to those of itraconazole and amphotericin B against the mold forms of 304 isolates of three dimorphic fungi, Blastomyces dermatitidis, Coccidioides immitis,...